Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension
Journal of Structural Biology · 2026-06 · 218 (2) · 108315
DOI: 10.1016/j.jsb.2026.108315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Structural Biology, 2026-06. Verfasst von Irina Borovikova und 6 weiteren Autor:innen. Beteiligte Einrichtung: International Bioinformatics Lab, Institute of Artificial Intelligence and Digital Sciences, HSE University, Pokrovsky Boulvard 11, 109028 Moscow, Ru…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Activin Receptors, Type II, Pulmonary Arterial Hypertension. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Research University Higher School of Economics.
Abstract (Originalsprache)
Single amino acid substitutions in the ATP-binding domain of ACVRL1, a key receptor in the bone morphogenetic protein (BMP) signaling pathway, are frequently classified as variants of uncertain significance (VUS), complicating molecular diagnosis for pulmonary arterial hypertension (PAH) and Hereditary Hemorrhagic Telangiectasia (HHT). Since aberrant ATP binding disrupts downstream SMAD1/5/8 phosphorylation, we employed molecular dynamics (MD) simulations to quantitatively assess the functional impact of these variants. We first validated our approach on 20 known pathogenic/likely pathogenic variants within 5Å of the ATP-binding site, finding that 18 (90%) caused significant alterations in binding affinity (|d| ≥ 0.8, p < 0.001). We then applied this protocol to all known VUS, conflicting, and unclassified variants within the same region, reclassifying 20 of 32 (63%) as likely pathogenic. Comprehensive in silico mutagenesis of all possible substitutions at ATP-binding pocket positions, combined with InterVar classification under HHT phenotype, enabled reclassification of 9 of 12 (75%) VUS as likely pathogenic. Finally, we demonstrated the applicability of this approach in two PAH patients with HHT carrying ACVRL1 VUS. This work establishes MD simulation of ATP-binding affinity as an effective and scalable tool for the functional interpretation of kinase variants, with broad potential for application across other disease-associated kinases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Bioinformatics Lab, Institute of Artificial Intelligence and Digital Sciences, HSE University, Pokrovsky Boulvard 11, 109028 Moscow, Russia; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow S…
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.
- International Bioinformatics Lab, Institute of Artificial Intelligence and Digital Sciences, HSE University, Pokrovsky Boulvard 11, 109028 Moscow, Russia.
- City Clinical Hospital No 29 by N.E. Bauman, Gospitalnaya Square, 2, 111020 Moscow, Russia.
- City Clinical Hospital No 29 by N.E. Bauman, Gospitalnaya Square, 2, 111020 Moscow, Russia. Electronic address: dz@bk.ru.
- International Bioinformatics Lab, Institute of Artificial Intelligence and Digital Sciences, HSE University, Pokrovsky Boulvard 11, 109028 Moscow, Russia. Electronic address: mpoptsova@hse.ru.
Förderung
- National Research University Higher School of Economics
Zitieren
APA
Borovikova, I., Uporov, I., Okhrimenko, G., Zamyatin, V., Dankovtseva, E., Zateyshchikov, D., & Poptsova, M. (2026). Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension. Journal of Structural Biology, 218(2), 108315. https://doi.org/10.1016/j.jsb.2026.108315
Vancouver
Borovikova I, Uporov I, Okhrimenko G, Zamyatin V, Dankovtseva E, Zateyshchikov D, et al. Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension. Journal of Structural Biology. 2026;218(2):108315. doi:10.1016/j.jsb.2026.108315
BibTeX
@article{Borovikova2026,
author = {Borovikova, Irina and Uporov, Igor and Okhrimenko, Galina and Zamyatin, Vladimir and Dankovtseva, Elena and Zateyshchikov, Dmitry and Poptsova, Maria},
title = {Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension},
journal = {Journal of Structural Biology},
year = {2026},
volume = {218},
number = {2},
pages = {108315},
doi = {10.1016/j.jsb.2026.108315}
}
EUVIMED